Hosted on MSN4d
Novavax Lands Wall Street 'Buy' Rating After Q4 Results, Retail Bulls Eye More Upside On Sanofi Partnership
Novavax Inc. (NVAX) shares climbed over 1% in after-hours trading Thursday as the vaccine maker's revenue outlook and ...
Novavax Sees Royalties, Reduced Expenses on COVID Vaccines From Sanofi Partnership
Novavax said it was eligible to receive royalties in high teens to low twenties percent on Sanofi sales, up to $350 million ...